Regulatory News
Wednesday, January 11, 2017
BRIEF-Redhill Biopharma announces QIDP fast-track designation granted by FDA to RHB-104 for nontuberculous mycobacteria infections
* Redhill Biopharma announces QIDP fast-track designation
granted by FDA to RHB-104 for nontuberculous mycobacteria
infections
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment